CODEPREX Drug Patent Profile
When do Codeprex patents expire, and what generic alternatives are available?
Codeprex is a drug marketed by Lannett Co Inc and is included in one NDA.
The generic ingredient in CODEPREX is chlorpheniramine polistirex; codeine polistirex. There is one drug master file entry for this compound. Additional details are available on the chlorpheniramine polistirex; codeine polistirex profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CODEPREX?
- What are the global sales for CODEPREX?
- What is Average Wholesale Price for CODEPREX?
Summary for CODEPREX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | CODEPREX at DailyMed |
US Patents and Regulatory Information for CODEPREX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lannett Co Inc | CODEPREX | chlorpheniramine polistirex; codeine polistirex | SUSPENSION, EXTENDED RELEASE;ORAL | 021369-001 | Jun 21, 2004 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |

